Amended Statement of Ownership (sc 13g/a)
2016年8月5日 - 5:40AM
Edgar (US Regulatory)
SCHEDULE 13G
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
Under
the Securities Exchange Act of 1934
(Amendment No. 3)*
XenoPort, Inc.
|
(Name of Issuer)
|
|
Common Stock, par value $0.001 per share
|
(Title of Class of Securities)
|
98411C100
|
(CUSIP Number)
|
|
July 31, 2016
|
(Date of Event which Requires Filing of this Statement)
|
Check the appropriate
box to designate the rule pursuant to which this Schedule is filed:
x
Rule 13d-1(b)
¨
Rule 13d-1(c)
¨
Rule 13d-1(d)
*The remainder of this
cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required
on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act, but shall be subject
to all other provisions of the Act (however, see the Notes).
CUSIP No.
98411C100
|
|
1
|
NAMES OF REPORTING PERSONS
Baker Bros. Advisors LP
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
|
(a)
¨
(b)
¨
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
0
|
6
|
SHARED VOTING POWER
-0-
|
7
|
SOLE DISPOSITIVE POWER
0
|
8
|
SHARED DISPOSITIVE POWER
-0-
|
9
|
AGGREGATE AMOUNT BENEFICIALLY
OWNED BY EACH REPORTING PERSON
0
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (See Instructions)
|
¨
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.0% (1)
|
12
|
TYPE OF REPORTING PERSON (See Instructions)
IA, PN
|
|
(1)
|
Based on 63,526,681 shares of the Issuer’s common stock outstanding as of April 15, 2016, as reported
in the Issuer’s 10-Q filed with the SEC on May 5, 2016.
|
CUSIP No.
98411C100
|
|
1
|
NAMES OF REPORTING PERSONS
Baker Bros. Advisors (GP) LLC
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
|
(a)
¨
(b)
¨
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
0
|
6
|
SHARED VOTING POWER
-0-
|
7
|
SOLE DISPOSITIVE POWER
0
|
8
|
SHARED DISPOSITIVE POWER
-0-
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
0
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (See Instructions)
|
¨
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.0% (1)
|
12
|
TYPE OF REPORTING PERSON (See Instructions)
HC, OO
|
|
(1)
|
Based on 63,526,681 shares of the Issuer’s common stock outstanding as of April 15, 2016, as reported
in the Issuer’s 10-Q filed with the SEC on May 5, 2016.
|
CUSIP No.
98411C100
|
|
1
|
NAMES OF REPORTING PERSONS
Felix J. Baker
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
|
(a)
¨
(b)
¨
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
0
|
6
|
SHARED VOTING POWER
-0-
|
7
|
SOLE DISPOSITIVE POWER
0
|
8
|
SHARED DISPOSITIVE POWER
-0-
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
0
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (See Instructions)
|
¨
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.0% (1)
|
12
|
TYPE OF REPORTING PERSON (See Instructions)
IN, HC
|
|
(1)
|
Based on 63,526,681 shares of the Issuer’s common stock outstanding as of April 15, 2016, as reported
in the Issuer’s 10-Q filed with the SEC on May 5, 2016.
|
CUSIP No.
98411C100
|
|
1
|
NAMES OF REPORTING PERSONS
Julian C. Baker
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
|
(a)
¨
(b)
¨
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
0
|
6
|
SHARED VOTING POWER
-0-
|
7
|
SOLE DISPOSITIVE POWER
0
|
8
|
SHARED DISPOSITIVE POWER
-0-
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
0
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (See Instructions)
|
¨
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.0% (1)
|
12
|
TYPE OF REPORTING PERSON (See Instructions)
IN, HC
|
|
(1)
|
Based on 63,526,681 shares of the Issuer’s common stock outstanding as of April 15, 2016, as reported
in the Issuer’s 10-Q filed with the SEC on May 5, 2016.
|
Amendment No. 3 to Schedule
13G
This Amendment No. 3 to Schedule 13G amends and supplements the previously filed Schedules 13G filed by
Baker Bros. Advisors LP (the “Adviser”). Baker Bros. Advisors (GP) LLC (the “Adviser GP”), Julian C. Baker
and Felix J. Baker. Except as supplemented herein, such statements, as heretofore amended and supplemented, remain in full force
and effect.
Item 1(a)
|
Name of Issuer:
|
|
|
|
XenoPort, Inc.
(the “Issuer”)
|
|
|
Item 1(b)
|
Address of Issuer’s Principal Executive Offices:
|
|
|
|
3410 Central Expressway
|
|
|
|
Santa Clara, California 95051
|
|
|
Item 2(a)
|
Name of Person Filing:
|
|
|
This Schedule 13G is being filed jointly by the Adviser, Adviser GP, Felix J. Baker and Julian C. Baker (collectively, the “Reporting Persons”).
|
|
|
Item 2(b)
|
Address of Principal Business Office or, if None, Residence:
|
|
|
|
The business address of each of the Reporting Persons is:
|
|
|
|
c/o Baker Bros. Advisors LP
|
|
|
|
667 Madison Avenue, 21
st
Floor
|
|
|
|
New York, NY 10065
|
|
|
|
(212) 339-5690
|
|
|
Item 2(c)
|
Citizenship:
|
|
|
|
The Adviser is a limited partnership organized under the laws of the State of Delaware. The Adviser GP is a limited liability company organized under the laws of the State of Delaware. The citizenship of each of Julian C. Baker and Felix J. Baker is the United States of America.
|
|
|
Item 2(d)
|
Title of Class of Securities
|
|
|
|
Common Stock, $0.001
par value per share (“Common Stock”)
|
|
|
Item 2(e)
|
CUSIP Number
|
|
|
98411C100
|
Item 3.
|
If this statement is filed pursuant to §§240.13d-1(b) or (c), check whether the person filing is a:
|
(a)
¨
Broker or dealer registered under Section 15 of the Exchange Act.
(b)
¨
Bank as defined in section 3(a)(6) of the Exchange Act.
(c)
¨
Insurance company as defined in section 3(a)(19) of the Exchange Act.
(d)
¨
Investment company registered under section 8 of the Investment Company Act of 1940.
(e)
x
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
(f)
¨
An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).
(g)
x
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
(h)
¨
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
(i)
¨
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act
of 1940.
(j)
¨
Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
IItems 5 through 9 and 11 of each of the cover pages to this
Amendment No. 3 are incorporated herein reference. Set forth below is the aggregate number of shares of Common Stock the Issuer
directly held by each of Baker Brothers Life Sciences, L.P. (“Life Sciences”), 14159, L.P. (“14159”),
and 667, L.P. (“667”, and together with Life Sciences and 14159, the “Funds”) and the percentage of the
Issuer’s outstanding shares of Common Stock such holdings represent. The information set forth below is based upon 63,526,681
shares of Common Stock outstanding as of April 15, 2016, as reported on the Issuer’s 10-Q filed with the SEC on May 5, 2016.
Such percentage figures are calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended.
|
|
Number of Shares of
|
|
|
|
|
|
|
Common Stock we own or
|
|
|
|
|
|
|
have the right to acquire
|
|
|
Percent of Class
|
|
Name
|
|
within 60 days
|
|
|
Outstanding
|
|
667, L.P.
|
|
|
-
|
|
|
|
0.0
|
%
|
Baker Brothers Life Sciences, L.P.
|
|
|
-
|
|
|
|
0.0
|
%
|
14159, L.P.
|
|
|
-
|
|
|
|
0.0
|
%
|
Total
|
|
|
-
|
|
|
|
0.0
|
%
|
Pursuant
to the amended and restated management agreements among the Adviser, the Funds and their respective general partners, the Adviser
has complete and unlimited discretion and authority with respect to the Funds’ investments and voting power over investments.
The Adviser GP, Felix J. Baker and Julian C. Baker as principals
of the Adviser GP, and the Adviser may be deemed to be beneficial owners of securities of the Issuer directly held by the Funds,
and may be deemed to have the power to vote or direct the vote of and the power to dispose or direct the disposition of such securities.
The Reporting Persons disclaim beneficial ownership of the securities held by each of the Funds, and this
Amendment No. 3 shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes
of Section 13(d) or for any other purpose.
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
If this statement is being
filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following
x
.
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person.
|
|
|
|
The information in Item
4 is incorporated herein by reference.
|
|
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
|
|
|
|
The information in Item
4 is incorporated herein by reference.
|
|
|
Item 8.
|
Identification and Classification of Members of the Group.
|
|
|
|
N/A
|
|
|
Item 9.
|
Notice of Dissolution of Group.
|
|
|
|
N/A
|
|
|
Item 10.
|
Certification.
|
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired
and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and
were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true, complete and correct.
August 4, 2016
|
BAKER BROS. ADVISORS LP
|
|
|
|
By: Baker Bros. Advisors (GP) LLC, its general partner
|
|
|
|
By:
|
/s/ Scott L. Lessing
|
|
|
Name: Scott L. Lessing
|
|
|
Title: President
|
|
BAKER BROS. ADVISORS (GP) LLC
|
|
|
|
|
By:
|
/s/ Scott L. Lessing
|
|
|
Name: Scott L. Lessing
|
|
|
Title: President
|
|
/s/ Julian C. Baker
|
|
Julian C. Baker
|
|
|
|
/s/ Felix J. Baker
|
|
Felix J. Baker
|
Xenoport, Inc. (NASDAQ:XNPT)
過去 株価チャート
から 5 2024 まで 6 2024
Xenoport, Inc. (NASDAQ:XNPT)
過去 株価チャート
から 6 2023 まで 6 2024